SLC1A5 and breast cancer: On basis of the network analysis and positive correlation of TALDO1 with SLC1A5 in luminal breast cancer, we performed further analysis with a focus on the potential clinical role of TALDO1 in luminal breast cancer and prediction of benefit from endocrine treatment.